Chris Moore discusses key considerations for US biotechs setting up gene therapy studies in Europe
![](https://boydconsultants.com/wp-content/uploads/2023/11/Website-news-cover-image-size-59.png)
In the viewpoint article: ‘Key considerations for US biotechs setting up gene therapy studies in the UK and Europe’, Chris highlights some of the important things organisations must consider before initiating their study.